References
- Falhammar H, Lindh JD, Calissendorff J, Skov J, Nathanson D,
Mannheimer B. Associations of proton pump inhibitors and
hospitalization due to hyponatremia: A population-based case-control
study. Eur J Intern Med . 2019;59:65-69.
- Han S, Kim J, Yim H, et al. Population pharmacokinetic analysis of
fluconazole to predict therapeutic outcome in burn patients with
Candida infection. Antimicrob Agents Chemother .
2013;57(2):1006-1011.
- Landes BD, Petite JP, Flouvat B. Clinical pharmacokinetics of
lansoprazole. Clin Pharmacokinet . 1995;28(6):458-470.
- Bown RL. An overview of the pharmacology, efficacy, safety and
cost-effectiveness of lansoprazole. Int J Clin Pract .
2002;56(2):132-139.
- Vukićević T, Hinze C, Baltzer S, et al. Fluconazole Increases Osmotic
Water Transport in Renal Collecting Duct through Effects on
Aquaporin-2 Trafficking. J Am Soc Nephrol . 2019;30(5):795-810.